Paper40938464
The functions and regulation of transcription factor YBX1 in cancers.
Qiu A and 4 others. Mol Biol Rep, 2025. Cited by 4 papers, by iCite.
Cite this record
ConductScience Library. The functions and regulation of transcription factor YBX1 in cancers. Papers, record 40938464. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/40938464
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
Topics8
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Y-Box-Binding Protein 1 | Major topic |
| Neoplasms | Major topic |
| Humans | |
| Gene Expression Regulation, Neoplastic | |
| Animals | |
| Cell Nucleus | |
| RNA Splicing | |
| DNA Repair |
Source PubMed
Grants6
Each grant PubMed's record writes, matched to the NIH project NIH's grant and paper links name for this paper, and each of those links the record does not write.
| Grant, as the record writes it | Agency | Country | NIH project | Stated by |
|---|---|---|---|---|
| 2022LCYJZD02 | the "1+X" program for Clinical Competency enhancement-Clinical Research Incubation Project of the Second Hospital of Dalian Medical University | PubMed | ||
| 2022LCYJZD02 | the "1+X" program for Clinical Competency enhancement-Clinical Research Incubation Project of the Second Hospital of Dalian Medical University | PubMed | ||
| 2022LCYJZD02 | the "1+X" program for Clinical Competency enhancement-Clinical Research Incubation Project of the Second Hospital of Dalian Medical University | PubMed | ||
| 2024-MSLH-108 | Liaoning Provincial Science and Technology Plan Project-General Project of the Joint Fund Project of Liaoning Provincial Science and Technology Plan | PubMed | ||
| 2024-MSLH-108 | Liaoning Provincial Science and Technology Plan Project-General Project of the Joint Fund Project of Liaoning Provincial Science and Technology Plan | PubMed | ||
| 2024-MSLH-108 | Liaoning Provincial Science and Technology Plan Project-General Project of the Joint Fund Project of Liaoning Provincial Science and Technology Plan | PubMed |
Source PubMed
References91
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 31358969 | 5-methylcytosine promotes pathogenesis of bladder cancer through stabilizing mRNAs. | Nat Cell Biol | 2019 | https://conductscience.org/library/papers/31358969 | PubMed |
| 2 | 36805592 | PLK1 inhibition promotes apoptosis and DNA damage in glioma stem cells by regulating the nuclear translocation of YBX1. | Cell Death Discov | 2023 | https://conductscience.org/library/papers/36805592 | PubMed |
| 3 | 38847599 | LNCHC directly binds and regulates YBX1 stability to ameliorate metabolic dysfunction-associated steatotic liver disease progression. | Liver Int | 2024 | https://conductscience.org/library/papers/38847599 | PubMed |
| 4 | 36211353 | 5-Methylcytosine (m5C) modification in peripheral blood immune cells is a novel non-invasive biomarker for colorectal cancer diagnosis. | Front Immunol | 2022 | https://conductscience.org/library/papers/36211353 | PubMed |
| 5 | 35260638 | YB1 associates with oncogenetic roles and poor prognosis in nasopharyngeal carcinoma. | Sci Rep | 2022 | https://conductscience.org/library/papers/35260638 | PubMed |
| 6 | 9759494 | The ubiquitin system. | Annu Rev Biochem | 1998 | https://conductscience.org/library/papers/9759494 | PubMed |
| 7 | 35273154 | SIAH1 reverses chemoresistance in epithelial ovarian cancer via ubiquitination of YBX-1. | Oncogenesis | 2022 | https://conductscience.org/library/papers/35273154 | PubMed |
| 8 | 32561752 | YBX1 mediates autophagy by targeting p110β and decreasing the sensitivity to cisplatin in NSCLC. | Cell Death Dis | 2020 | https://conductscience.org/library/papers/32561752 | PubMed |
| 9 | 24378923 | Prostaglandin E2 promotes hepatocellular carcinoma cell invasion through upregulation of YB-1 protein expression. | Int J Oncol | 2014 | https://conductscience.org/library/papers/24378923 | PubMed |
| 10 | 35292781 | Gasdermin E mediates resistance of pancreatic adenocarcinoma to enzymatic digestion through a YBX1-mucin pathway. | Nat Cell Biol | 2022 | https://conductscience.org/library/papers/35292781 | PubMed |
| 11 | 39216548 | YBX1 as a therapeutic target to suppress the LRP1-β-catenin-RRM1 axis and overcome gemcitabine resistance in pancreatic cancer. | Cancer Lett | 2024 | https://conductscience.org/library/papers/39216548 | PubMed |
| 12 | 18851979 | RBBP6 interacts with multifunctional protein YB-1 through its RING finger domain, leading to ubiquitination and proteosomal degradation of YB-1. | J Mol Biol | 2008 | https://conductscience.org/library/papers/18851979 | PubMed |
| 13 | 35501989 | Role of YB-1 Protein in Inflammation. | Biochemistry (Mosc) | 2022 | https://conductscience.org/library/papers/35501989 | PubMed |
| 14 | 30258867 | Role of post-translational modification of the Y box binding protein 1 in human cancers. | Genes Dis | 2015 | https://conductscience.org/library/papers/30258867 | PubMed |
| 15 | 34991621 | CTPS1 promotes malignant progression of triple-negative breast cancer with transcriptional activation by YBX1. | J Transl Med | 2022 | https://conductscience.org/library/papers/34991621 | PubMed |
| 16 | 39400789 | YBX1 promotes epithelial-mesenchymal transition in hepatocellular carcinoma via transcriptional regulation of PLRG1. | Med Oncol | 2024 | https://conductscience.org/library/papers/39400789 | PubMed |
| 17 | 31178151 | Nasopharyngeal carcinoma. | Lancet | 2019 | https://conductscience.org/library/papers/31178151 | PubMed |
| 18 | 36600625 | Circ_0002762 Regulates Oncoprotein YBX1 in Cervical Cancer via mir-375 to Regulate the Malignancy of Cancer Cells. | Protein Pept Lett | 2023 | https://conductscience.org/library/papers/36600625 | PubMed |
| 19 | 31906126 | Inhibition of Transcription Induces Phosphorylation of YB-1 at Ser102 and Its Accumulation in the Nucleus. | Cells | 2019 | https://conductscience.org/library/papers/31906126 | PubMed |
| 20 | 22406545 | EMT as the ultimate survival mechanism of cancer cells. | Semin Cancer Biol | 2012 | https://conductscience.org/library/papers/22406545 | PubMed |
Cited by3
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 4 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42698848 | YBX1 as an adaptive RNA hub in cancer: linking state-dependent RNA regulation to tumor immunity, metabolic reprogramming, and therapy resistance. | Front Immunol | 2026 | https://conductscience.org/library/papers/42698848 | PubMed |
| 42246500 | Human lncRNA, hLinfRNA7 (IDO1-AS) Regulates Cytokine Expression, Tryptophan Catabolism, and Inflammatory Response in Macrophage. | Mol Cell Biol | 2026 | https://conductscience.org/library/papers/42246500 | PubMed |
| 41994112 | YBX1 Promotes Drug Resistance in Hepatocellular Carcinoma and Serves as a Potential Therapeutic Target. | Res Sq | 2026 | https://conductscience.org/library/papers/41994112 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| YBX1 | 4904 | PubTator's text mining | https://conductscience.org/library/genes/4904 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Trials
- Comments and corrections
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/40938464
GET https://conductscience.org/api/papers/v1/40938464/references?page=2